关键词：结肠直肠癌；直肠；恶性肿瘤；腺癌；外科手术；化学治疗；生物制品；辐射治疗疗法
摘 要：Colorectal cancer (or bowel cancer) refers to malignancies that originate in the rectum or the colon. The formation of adenocarcinomas is the most common feature of colorectal cancer. This type of cancer starts as a benign or malignant polyp in the inner wall of the colon or the rectum. The risk factors for colorectal cancer include an unhealthy lifestyle, age, genetic disorders, family history, and inflammatory bowel disease. Some of the symptoms of the cancer include rectal bleeding, decreased appetite, constipation, significant or unexplained weight loss, nausea, bloating, and pelvic pain. It is treated with surgical, chemotherapeutic, biologic, and radiation therapies.
目 录：

01. Executive Summary

02. List of Abbreviations

03. Scope of the Report

03.1 Market Overview

03.2 Product Offerings

04. Market Research Methodology

04.1 Market Research Process

04.2 Research Methodology

05. Introduction

06. Disease Overview

06.1 Understanding the Disease

06.2 Pathophysiology

06.3 Epidemiology

06.4 Diagnosis

06.5 Staging

06.5.1 Staging: Colon Cancer

06.5.2 Staging: Rectal Cancer

06.6 Management

06.7 Economic Burden

07. Market Landscape

07.1 Market Overview

07.2 Market Size and Forecast

07.3 Colorectal Cancer Drugs Market in US

07.3.1 Market Size and Forecast

07.4 Colorectal Cancer Drugs Market in Germany

07.4.1 Market Size and Forecast

07.5 Colorectal Cancer Drugs Market in Spain

07.5.1 Market Size and Forecast

07.6 Colorectal Cancer Drugs Market in Japan

07.6.1 Market Size and Forecast

07.7 Colorectal Cancer Drugs Market in China

07.7.1 Market Size and Forecast

07.8 Five Forces Analysis

08. Market Segmentation by Type of Molecules

08.1 Small Molecules

08.2 Biologics

09. Market Segmentation by Route of

Administration

09.1 Oral

09.2 Parenteral

10. Geographical Segmentation

10.1.1 Market Size and Forecast

10.2 Colorectal Cancer Drugs Market in Americas

10.2.1 Market Size and Forecast

10.3 Colorectal Cancer Drugs Market in EMEA

10.4 Colorectal Cancer Drugs Market in APAC

10.4.1 Market Size and Forecast

11. Key Leading Countries

11.1 US

11.2 Japan

11.3 Germany

11.4 Spain

11.5 China

12. Buying Criteria

13. Market Growth Drivers

14. Drivers and their Impact

15. Market Challenges

16. Impact of Drivers and Challenges

17. Market Trends

18. Trends and their Impact

19. Vendor Landscape

19.1 Competitive Scenario

19.1.1 Key News

19.1.2 Mergers and Acquisitions

19.2 Market Analysis 2014

19.2.1 Competitive Assessment of Top Drugs for Colorectal

Cancer

19.2.2 F. Hoffmann-La Roche

19.2.3 Merck Serono

19.2.4 Bristol-Myers Squibb

19.2.5 Amgen

19.2.6 Sanofi

19.2.7 Bayer

19.3 Other and Future Prominent Vendors

20. Key Takeaways

21. Key Vendor Analysis

21.1 Amgen

21.1.1 Key Facts

21.1.2 Business Overview

21.1.3 Business Segmentation by Revenue 2013

21.1.4 Product Portfolio by Revenue 2013

21.1.5 Business Segmentation by Revenue 2012 and 2013

21.1.6 Geographical Segmentation by Revenue 2013

21.1.7 Business Strategy

21.1.8 Recent Developments

21.1.9 SWOT Analysis

21.2 Bayer

21.2.1 Key facts

21.2.2 Business overview

21.2.3 Business segmentation by revenue 2014

21.2.4 Business segmentation by revenue 2013 and 2014

21.2.5 Geographical segmentation by revenue 2014

21.2.6 Business strategy

21.2.7 Recent developments

21.2.8 SWOT analysis

21.3 Bristol-Myers Squibb

21.3.1 Key Facts

21.3.2 Business Overview

21.3.3 Key Product Offerings

21.3.4 Revenue by Geography

21.3.5 Business Strategy

21.3.6 Key Information

21.3.7 SWOT Analysis

21.4 F. Hoffmann-La Roche

21.4.1 Key Facts

21.4.2 Business Overview

21.4.3 Business Segmentation

21.4.4 Business Segmentation by Revenue 2012 and 2013

21.4.5 Sales by Geography

21.4.6 Business Strategy

21.4.7 Key Information

21.4.8 SWOT Analysis

21.5 Merck Serono

21.5.1 Key Facts

21.5.2 Business Overview

21.5.3 Geographical Segmentation by Revenue 2013

21.5.4 Business Strategy

21.5.5 Recent Developments

21.5.6 SWOT Analysis

21.6 Sanofi SA

21.6.1 Key Facts

21.6.2 Business Description

21.6.3 Business Segmentation

21.6.4 Revenue by Business Segmentation

21.6.5 Revenue Comparison 2012 and 2013

21.6.6 Sales by Geography

21.6.7 Business Strategy

21.6.8 Key Developments

21.6.9 SWOT Analysis

22. Other Reports in this Series